Keyphrases
Pichinde Virus
97%
Recombinant
88%
Arenavirus
68%
Lassa Virus
48%
Nucleoprotein
42%
Retinoic Acid-inducible Gene I (RIG-I)
32%
Immune Response
28%
Viral Replication
27%
Influenza Virus
26%
Viral-vectored Vaccine
26%
Type I Interferon
25%
Precursor mRNA
25%
Virus
24%
B19V
24%
Parvovirus B19
24%
Porcine Reproductive and Respiratory Syndrome Virus
24%
Swine
23%
Reverse Genetics
22%
Hemorrhagic Fever
21%
Guinea pig
18%
Protective Efficacy
17%
Lymphocytic Choriomeningitis Virus
17%
Alternative Polyadenylation
17%
Vaccine Vector
17%
Virus Infection
16%
Aleutian Mink Disease Virus
16%
Hartley Guinea pig
16%
Outbred
16%
Protein Z
16%
Molecular Characterization
16%
Approved Drugs
16%
Biological Role
14%
Exoribonuclease
14%
Viral Vectors
14%
Immunogenicity
14%
Lassa Fever
14%
Mammarenavirus
13%
Glycoprotein
12%
Vector-based
12%
Non-structural Protein
11%
Alternative Splicing
11%
Parvoviridae
10%
Interferon Production
10%
Viral
10%
Viral Infection
10%
SARS-CoV-2 Infection
10%
Virulence
10%
Small Animal Model
10%
Trivalent
10%
Immunogenic
10%
Immunology and Microbiology
Pichinde Virus
100%
Infection
64%
Lassa Virus
52%
Virus
47%
Nucleoprotein
43%
Arenavirus
38%
Immune Response
35%
Arenaviridae
35%
RIG-I
32%
Viral Replication
30%
Viral Disease
30%
Replication
28%
Interferon Type I
26%
Hemorrhagic Fever
24%
Porcine Reproductive and Respiratory Syndrome Virus
24%
Influenzavirus A
24%
Glycoprotein
22%
Ribonucleic Acid
21%
In Vitro
20%
Precursor
19%
Viral Vector
18%
Cell Line
18%
Lymphocytic Choriomeningitis Virus
18%
Guinea Pig
18%
Polyadenylation
17%
Aleutian Mink Disease Virus
16%
Human Parvovirus B19
16%
Hartley Guinea Pig
16%
Pseudorabies Virus
16%
Mammarenavirus
14%
Immunogenicity
14%
Innate Immune System
13%
Hemagglutinin
13%
Infectious Agent
12%
RNA Synthesis
11%
Capsid
11%
T Cell
10%
Amino Terminal Sequence
10%
Interferon Production
10%
Parvoviridae
10%
Plasmid
10%
DNA Synthesis
10%
Adoptive Immunity
10%
Serotype
10%
Double-Stranded RNA
9%
Virion
9%
Alternative RNA Splicing
9%
Airway
9%
MDA5
8%
Tyrosine
8%